Observational studyArthritis care & research2017

Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study.

Ernest H Choy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.